NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 2, 2026 $3.95 +4.80% $3.97 V 99.52% 5
Feb 2, 2026 $3.88 +3.00% $3.97 V 97.81% 1
Feb 2, 2026 $4.21 +11.67% $3.97 V 93.95% 1
Jan 30, 2026 Bullish $3.77 X 0
Jan 30, 2026 $4.08 +4.83% $3.77 X 91.83% 0
Jan 30, 2026 $4.01 +3.02% $3.77 X 93.70% 0
Jan 30, 2026 Bullish $3.77 X 0
Jan 28, 2026 $4.59 +4.23% $3.97 X 84.33% 0
Jan 28, 2026 $4.28 -2.65% $3.97 V 91.96% 1
Jan 28, 2026 Bullish $3.97 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE